Sholl et al. analyzed women who did not smoke and who were of East Asian origin with lung adenocarcinomas and found that EGFR amplification was associated with solid histology, advanced clinical stage, and a worse outcome in univariate analysis [20]. This evidence concerns the gene EGFR and lung adenocarcinoma.